TIM-1 is a mucin-like class I integral membrane glycoprotein [20] considered as an emerging clinical biomarker associated with aggressiveness in oncological processes and cancer angiogenesis [S1–S5], and other prevalent diseases [S6–S9]. This evidence concerns the gene HAVCR1 and cancer.